[HTML][HTML] Purkinje cell signaling deficits in animal models of ataxia

E Hoxha, I Balbo, MC Miniaci, F Tempia - Frontiers in synaptic …, 2018 - frontiersin.org
Purkinje cell (PC) dysfunction or degeneration is the most frequent finding in animal models
with ataxic symptoms. Mutations affecting intrinsic membrane properties can lead to ataxia …

[HTML][HTML] Aberrant cerebellar circuitry in the spinocerebellar ataxias

KJ Robinson, M Watchon, AS Laird - Frontiers in neuroscience, 2020 - frontiersin.org
The spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative
diseases that share convergent disease features. A common symptom of these diseases is …

Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6

AA Cook, S Jayabal, J Sheng, E Fields, TCS Leung… - Science …, 2022 - science.org
Spinocerebellar ataxia type 6 (SCA6) is a neurodegenerative disease resulting in motor
coordination deficits and cerebellar pathology. Expression of brain-derived neurotrophic …

[HTML][HTML] A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS

BT Márquez, TCS Leung, J Hui, F Charron… - Neurobiology of …, 2023 - Elsevier
Mitochondrial deficits have been observed in animal models of Autosomal-recessive spastic
ataxia of Charlevoix-Saguenay (ARSACS) and in patient-derived fibroblasts. We …

[HTML][HTML] 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6

S Jayabal, HHV Chang, KE Cullen, AJ Watt - Scientific reports, 2016 - nature.com
Abstract Spinocerebellar ataxia type 6 (SCA6) is a devastating midlife-onset autosomal
dominant motor control disease with no known treatment. Using a hyper-expanded …

Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse …

X Qiu, Q Wang, L Hou, C Zhang, Q Wang, X Zhao - Toxicology Letters, 2021 - Elsevier
Pesticides exposure can lead to damage of dopaminergic neurons, which are associated
with increased risk of Parkinson's disease (PD). However, the etiology of PD remains poorly …

Consensus paper: strengths and weaknesses of animal models of spinocerebellar ataxias and their clinical implications

J Cendelin, M Cvetanovic, M Gandelman, H Hirai… - The Cerebellum, 2022 - Springer
Spinocerebellar ataxias (SCAs) represent a large group of hereditary degenerative diseases
of the nervous system, in particular the cerebellum, and other systems that manifest with a …

[HTML][HTML] What is the pathogenic CAG expansion length in Huntington's disease?

J Donaldson, S Powell, N Rickards… - Journal of …, 2021 - content.iospress.com
Abstract Huntington's disease (HD)(OMIM 143100) is caused by an expanded CAG repeat
tract in the HTT gene. The inherited CAG length is known to expand further in somatic and …

Tissue beads: tissue‐specific extracellular matrix microbeads to potentiate reprogrammed cell‐based therapy

JS Lee, YH Roh, YS Choi, Y Jin, EJ Jeon… - Advanced Functional …, 2019 - Wiley Online Library
Microbeads have been utilized as efficient cell culture carriers and injectable scaffolds for
cell transplantation. However, various polymers currently used to generate microbeads have …

Endosomal dysfunction contributes to cerebellar deficits in spinocerebellar ataxia type 6

AA Cook, TCS Leung, M Rice, M Nachman… - Elife, 2023 - elifesciences.org
Abstract Spinocerebellar ataxia type 6 (SCA6) is a rare disease that is characterized by
cerebellar dysfunction. Patients have progressive motor coordination impairment, and …